ECIS Highlights Increase in Lung Cancer Among Women in Europe

🌍 Latest Cancer Mapping Shows Key Trends Across Europe

The updated European Cancer Information System (ECIS) updated its epidemiological data, showing a significant increase in lung cancer cases among women, while a decrease is observed among men.! Managed by the JRC and powered by data from over 125 cancer registries across 32 countries, ECIS offers invaluable insights into cancer incidence and mortality trends across Europe. 📊

🔹 Key Findings:

📈 Lung Cancer: Cases among women are rising, while incidence in men is declining.
📉 Stomach Cancer: Both incidence and mortality rates are steadily decreasing.
💗 Breast Cancer: Still the most diagnosed cancer in women, but mortality is on the decline thanks to advancements in care.

ECIS not only helps us understand these trends but also drives targeted policymaking, public awareness, and research. Let’s continue to support this critical work and improve cancer prevention and control across Europe.

👉 Explore the data and trends here: [Link to ECIS website]

#EuCanScreen #CancerScreening #HealthCare #CancerPrevention #LungCancer

🔗 Please don’t forget to Subscribe to EuCanScreen Newsletter! 💪

Subscribe to our newsletter to get news and updates.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor HADEA can be held responsible for them.

The general objective of EUCanScreen is to assure sustainable implementation of high-quality screening for breast, cervical and colorectal cancers, as well as implementation of the recently recommended screening programs – for lung, prostate and gastric cancers. EUCanScreen will facilitate the reduction of cancer burden and achieving equity across the EU.

This project has received funding from the European Union’s EU4HEALTH Programme under the Grant Agreement no 101162959